Identification of a proliferatoractivated receptor-γ antagonist for the treatment of type 2 diabetes mellitus

E-ISSN： 1792-1015|9|2|446-450

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.9, Iss.2, 2015-01, pp. : 446-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of a selective glucocorticoid receptor ligand for the treatment of chronic inflammation in type 2 diabetes mellitus

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1111-1114

Spandidos Publications

Access to resources Recommend Favorite

Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 783-788

Spandidos Publications

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor-γ target genes

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 419-424

Spandidos Publications

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1259-1266

Spandidos Publications

Access to resources Recommend Favorite